This is an extremely important point and I thought the exact same thing.
If Rem-l was looking like not going to be approved by the FDA they would not commit those large FDA resources to the MSB cause.
Ann: MSB Reports Q3 Financial Results and Operational Highlights, page-212
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.135(10.0%) |
Mkt cap ! $1.724B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $21.64M | 14.85M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 18304 | $1.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 1018 | 4 |
View Market Depth
| Last trade - 15.39pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |